• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物信息学预测 SARS-CoV-2 刺突蛋白和核衣壳蛋白中的 B 细胞和 T 细胞表位。

Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2.

机构信息

Department of Microbial Biotechnology, Genetic Engineering Division, National Research Centre, 33 EL Bohouth Street, Dokki, Giza 12622, Egypt.

Biological Anthropology Department, Medical Research Division, National Research Centre, Dokki, Giza, Egypt.

出版信息

J Infect Public Health. 2021 Feb;14(2):169-178. doi: 10.1016/j.jiph.2020.12.006. Epub 2020 Dec 15.

DOI:10.1016/j.jiph.2020.12.006
PMID:33486372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7737509/
Abstract

BACKGROUND

The striking difference in severity of SARS CoV2 infection among global population is partly attributed to viral factors. With the spike (S) and nucleocapsid (N) are the most immunogenic subunits, genetic diversity and antigenicity of S and N are key players in virulence and in vaccine development.

AIM

This paper aims at identifying immunogenic targets for better vaccine development and/or immunotherapy of COVID 19 pandemic.

METHODS

18 complete genomes of SARS CoV2 (n=14), SARS CoV (n=2) and MERS CoV (n=2) were examined. Bioinformatics of viral genetics and protein folding allowed functional tuning of NH2 Terminal Domain (NTD) of S protein and development of epitope maps for B and T cell responses.

CONCLUSION

A deletion of amino acid residues Y144 and G107 were discovered in NTD of S protein derived from Indian and French isolates resulting in altered pocket structure exclusively located in NTD and reduced affinity of NTD binding to endogenous nAbs and disrupted NTD mediated cell entry. We therefore, proposed a set of B and T cell epitopes based on Immune Epitope Database, homologous epitopes for nAbs in convalescent plasma post SARS CoV infection and functional domains of S (NTD, Receptor Binding domain and the unique polybasic Furin cleavage site at S1/S2 junction). Nevertheless, laboratory data are required to develop vaccine and immunotherapeutics.

摘要

背景

全球人群中严重程度不同的 SARS-CoV-2 感染部分归因于病毒因素。刺突(S)和核衣壳(N)是最具免疫原性的亚单位,S 和 N 的遗传多样性和抗原性是病毒毒力和疫苗开发的关键因素。

目的

本文旨在确定免疫原性靶标,以更好地开发 COVID-19 大流行的疫苗和/或免疫疗法。

方法

检查了 18 株完整的 SARS-CoV-2(n=14)、SARS-CoV(n=2)和 MERS-CoV(n=2)基因组。病毒遗传学和蛋白质折叠的生物信息学允许对 S 蛋白的 NH2 末端结构域(NTD)进行功能调整,并开发 B 细胞和 T 细胞反应的表位图谱。

结论

在源自印度和法国分离株的 S 蛋白的 NTD 中发现了氨基酸残基 Y144 和 G107 的缺失,导致口袋结构发生改变,仅位于 NTD 中,降低了 NTD 与内源性 nAbs 的结合亲和力,并破坏了 NTD 介导的细胞进入。因此,我们根据免疫表位数据库、SARS-CoV 感染后恢复期血浆中的 nAbs 同源表位以及 S 的功能域(NTD、受体结合域和 S1/S2 交界处独特的多碱性弗林切割位点)提出了一组 B 和 T 细胞表位。然而,需要实验室数据来开发疫苗和免疫疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ae/7737509/4255dc8b03d1/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ae/7737509/80a05713dc4b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ae/7737509/889cb4eeceb8/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ae/7737509/4255dc8b03d1/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ae/7737509/80a05713dc4b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ae/7737509/889cb4eeceb8/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ae/7737509/4255dc8b03d1/gr3_lrg.jpg

相似文献

1
Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2.生物信息学预测 SARS-CoV-2 刺突蛋白和核衣壳蛋白中的 B 细胞和 T 细胞表位。
J Infect Public Health. 2021 Feb;14(2):169-178. doi: 10.1016/j.jiph.2020.12.006. Epub 2020 Dec 15.
2
Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.鉴定 SARS-CoV-2 核衣壳和刺突 T 细胞表位以评估 T 细胞免疫。
J Virol. 2021 Feb 24;95(6). doi: 10.1128/JVI.02002-20.
3
COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.基于全球人群中 HLA Ⅰ类基因座(HLA-A、-B、-C)分布的 COVID-19 冠状病毒疫苗 T 细胞表位预测分析。
Hum Vaccin Immunother. 2021 Apr 3;17(4):1097-1108. doi: 10.1080/21645515.2020.1823777. Epub 2020 Nov 11.
4
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.基于 SARS-CoV 免疫学研究的 COVID-19 冠状病毒(SARS-CoV-2)潜在疫苗靶点的初步鉴定。
Viruses. 2020 Feb 25;12(3):254. doi: 10.3390/v12030254.
5
Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.基于表位的新型 SARS-CoV-2 疫苗设计的生物信息学分析。
Infect Dis Poverty. 2020 Jul 10;9(1):88. doi: 10.1186/s40249-020-00713-3.
6
Human CD4 T cells specific for dominant epitopes of SARS-CoV-2 Spike and Nucleocapsid proteins with therapeutic potential.人类针对 SARS-CoV-2 刺突蛋白和核衣壳蛋白优势表位的 CD4 T 细胞具有治疗潜力。
Clin Exp Immunol. 2021 Sep;205(3):363-378. doi: 10.1111/cei.13627. Epub 2021 Jun 29.
7
Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.揭示 SARS-CoV-2 未注释的 ORF 抗原中存在的有效表位,为基于表位的多价疫苗设计提供免疫信息学方法。
Front Immunol. 2021 Aug 23;12:692937. doi: 10.3389/fimmu.2021.692937. eCollection 2021.
8
In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19.基于 SARS-CoV-2 的抗原蛋白和表位的计算机发现,以开发 COVID-19 的疫苗或诊断方法。
Sci Rep. 2020 Dec 28;10(1):22387. doi: 10.1038/s41598-020-79645-9.
9
Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay.通过免疫信息学预测和免疫测定鉴定的新型冠状病毒2型刺突蛋白和膜蛋白中的免疫显性线性B细胞表位
Sci Rep. 2021 Oct 14;11(1):20383. doi: 10.1038/s41598-021-99642-w.
10
Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study.基于生物信息学和免疫信息学的 SARS-CoV-2 核衣壳蛋白免疫优势区域预测用于早期诊断。
Pathog Glob Health. 2020 Dec;114(8):463-470. doi: 10.1080/20477724.2020.1838190. Epub 2020 Nov 16.

引用本文的文献

1
Linear B-cell epitope prediction for SARS and COVID-19 vaccine design: Integrating balanced ensemble learning models and resampling strategies.用于SARS和COVID-19疫苗设计的线性B细胞表位预测:集成平衡集成学习模型和重采样策略
PeerJ Comput Sci. 2025 Jun 18;11:e2970. doi: 10.7717/peerj-cs.2970. eCollection 2025.
2
Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do Sul.基因组监测和针对南里奥格兰德州主要 SARS-CoV-2 XBB 谱系的疫苗反应。
Sci Rep. 2024 Jul 22;14(1):16831. doi: 10.1038/s41598-024-67828-7.
3
Bioinformatics analysis of multi-epitope peptide vaccines against Hepatitis C virus: a molecular docking study.

本文引用的文献

1
Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an study.反向疫苗学方法设计针对 COVID-19 的新型多表位疫苗候选物:一项研究。
J Biomol Struct Dyn. 2021 May;39(8):2857-2872. doi: 10.1080/07391102.2020.1756411. Epub 2020 May 2.
2
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.通过计算方法分析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的治疗靶点并发现潜在药物
Acta Pharm Sin B. 2020 May;10(5):766-788. doi: 10.1016/j.apsb.2020.02.008. Epub 2020 Feb 27.
3
The proximal origin of SARS-CoV-2.
丙型肝炎病毒多表位肽疫苗的生物信息学分析:一项分子对接研究
J Genet Eng Biotechnol. 2023 Nov 14;21(1):117. doi: 10.1186/s43141-023-00583-w.
4
Identifying featured indels associated with SARS-CoV-2 fitness.识别与新冠病毒适应性相关的特征性插入缺失。
Microbiol Spectr. 2023 Sep 12;11(5):e0226923. doi: 10.1128/spectrum.02269-23.
5
In Silico Analysis of a Candidate Multi-epitope Peptide Vaccine Against Human Brucellosis.针对人类布鲁氏菌病的候选多表位肽疫苗的计算机模拟分析
Mol Biotechnol. 2024 Apr;66(4):769-783. doi: 10.1007/s12033-023-00698-y. Epub 2023 Mar 20.
6
Genomic landscape of alpha-variant of SARS-CoV-2 circulated in Pakistan.巴基斯坦流行的 SARS-CoV-2 阿尔法变异株的基因组特征。
PLoS One. 2022 Dec 13;17(12):e0276171. doi: 10.1371/journal.pone.0276171. eCollection 2022.
7
Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein.鉴定新型冠状病毒刺突蛋白上的三个保守线性 B 细胞表位。
Emerg Microbes Infect. 2022 Dec;11(1):2120-2131. doi: 10.1080/22221751.2022.2109515.
8
Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain.抗体对 SARS-CoV-2 S2 结构域的结合和中和能力。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2055373. doi: 10.1080/21645515.2022.2055373. Epub 2022 Apr 13.
9
Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response.新型 T 细胞干扰素γ释放试验(IGRA),使用 Spike 重组蛋白作为 COVID19 疫苗应答指标,使用核衣壳蛋白作为 SARS-CoV-2 应答指标。
Clin Immunol. 2022 Apr;237:108979. doi: 10.1016/j.clim.2022.108979. Epub 2022 Mar 14.
10
Conserved Pattern and Potential Role of Recurrent Deletions in SARS-CoV-2 Evolution.新冠病毒进化过程中反复出现的缺失的保守模式及潜在作用
Microbiol Spectr. 2022 Apr 27;10(2):e0219121. doi: 10.1128/spectrum.02191-21. Epub 2022 Mar 7.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的近端起源。
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
4
A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin.关于冠状病毒刺突蛋白通过血管紧张素转换酶-2 和弗林蛋白酶进行裂解激活的综述。
J Biomol Struct Dyn. 2021 May;39(8):3025-3033. doi: 10.1080/07391102.2020.1754293. Epub 2020 Apr 22.
5
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.恢复期血浆疗法治疗重症 COVID-19 患者的疗效。
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.
6
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.针对 SARS-CoV-2 和其他人类冠状病毒的中和抗体。
Trends Immunol. 2020 May;41(5):355-359. doi: 10.1016/j.it.2020.03.007. Epub 2020 Apr 2.
7
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
8
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines.新型冠状病毒肺炎的爆发需要病毒疫苗。
NPJ Vaccines. 2020 Mar 6;5(1):18. doi: 10.1038/s41541-020-0170-0. eCollection 2020.
9
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
10
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.严重急性呼吸系统综合征冠状病毒 2 刺突糖蛋白的结构、功能和抗原性。
Cell. 2020 Apr 16;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058. Epub 2020 Mar 9.